On February 22, 2022, a new regulation kicked into effect in the EU for infant formulas and follow-on formulas containing protein hydrolysates, requiring companies to submit dossiers on their ingredients so that EFSA can evaluate their safety and suitability for use in these products.
The European Food Safety Authority (EFSA) published a positive opinion acknowledging that Arla Foods Ingredients’ Peptigen IF-3080 protein hydrolysate ingredient is safe for use in infant formulas and follow-on formulas in the EU.
On February 22, 2022, a new regulation kicked into effect in the EU for infant formulas and follow-on formulas containing protein hydrolysates, requiring companies to submit dossiers on their ingredients so that EFSA can evaluate their safety and suitability for use in these products. Ingredients not approved cannot be sold in the market in these products.
Arla Foods Ingredients’ Peptigen IF-3080 is “one of only a few milk protein hydrolysate ingredients to receive a positive EFSA opinion to date,” the company stated in a March 2022 press release.
“We are delighted by this opinion, which supports our reputation for having the industry’s highest levels of quality, innovation, and food safety,” stated Anders Steen Jørgensen, head of SBU Pediatric, Arla Foods Ingredients, in the press release.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.